

Cover Story
The American Cancer Society said that Karen E. Knudsen “announced her desire to transition” from her role as CEO of the 111-year-old charity in order to pursue “the next phase of her strategy to accelerate progress against cancer.”
In Brief
Clinical Roundup


Drugs & Targets


Trending Stories
- House passes three-year extension of ACA subsidies with bipartisan support
- A planned randomized trial will ask an intriguing question: Do COVID vaccines potentiate checkpoint inhibitors?
- Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem
- NIH agrees to review hundreds of denied or shelved grant applications
- Mikaela Naylon Give Kids a Chance Act nixed by Senate
- Nancy Goodman: “Sen. Sanders says he cares about kids with cancer. I’m just asking him to show us.”

















